Amongst all the RTKs discussed, EGFR appears to regulate various stages in NAFLD, starting from lipid accumulation to inflammation, oxidative stress and even fibrosis. This evidence concerns the gene EGFR and metabolic dysfunction-associated steatotic liver disease.